454 related articles for article (PubMed ID: 18452527)
1. Period of remission after treatment with UVA-1 in sclerodermic skin diseases.
Kroft EB; van de Kerkhof PC; Gerritsen MJ; de Jong EM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):839-44. PubMed ID: 18452527
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
Kroft EB; Creemers MC; van den Hoogen FH; Boezeman JB; de Jong EM
Br J Dermatol; 2009 May; 160(5):1075-82. PubMed ID: 19210503
[TBL] [Abstract][Full Text] [Related]
3. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
[TBL] [Abstract][Full Text] [Related]
4. UVA/UVB phototherapy for atopic dermatitis revisited.
Valkova S; Velkova A
J Dermatolog Treat; 2004 Jul; 15(4):239-44. PubMed ID: 15764039
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
[TBL] [Abstract][Full Text] [Related]
6. Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study.
El-Mofty M; Mostafa W; Esmat S; Youssef R; Bousseila M; Nagi N; Shaker O; Abouzeid A
Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):93-100. PubMed ID: 15030594
[TBL] [Abstract][Full Text] [Related]
7. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half-side comparison analysis.
Durand F; Staumont D; Bonnevalle A; Hachulla E; Hatron PY; Thomas P
Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):215-21. PubMed ID: 17986056
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
11. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis.
El-Mofty M; Mostafa W; El-Darouty M; Bosseila M; Nada H; Yousef R; Esmat S; El-Lawindy M; Assaf M; El-Enani G
Photodermatol Photoimmunol Photomed; 2004 Jun; 20(3):148-56. PubMed ID: 15144393
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
[TBL] [Abstract][Full Text] [Related]
13. Low-dose UVA₁ phototherapy for scleroderma: what benefit can we expect?
Pereira N; Santiago F; Oliveira H; Figueiredo A
J Eur Acad Dermatol Venereol; 2012 May; 26(5):619-26. PubMed ID: 21635565
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of connective tissue disorder-related acral syndromes using UVA-1 phototherapy. An open study of 11 cases].
Comte C; Bessis D; Picot E; Peyron JL; Guillot B; Dereure O
Ann Dermatol Venereol; 2009 Apr; 136(4):323-9. PubMed ID: 19361698
[TBL] [Abstract][Full Text] [Related]
15. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review.
Kroft EB; Berkhof NJ; van de Kerkhof PC; Gerritsen RM; de Jong EM
J Am Acad Dermatol; 2008 Dec; 59(6):1017-30. PubMed ID: 18835066
[TBL] [Abstract][Full Text] [Related]
16. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study.
Borzova E; Rutherford A; Konstantinou GN; Leslie KS; Grattan CE
J Am Acad Dermatol; 2008 Nov; 59(5):752-7. PubMed ID: 18774200
[TBL] [Abstract][Full Text] [Related]
17. Phototherapy for atopic dermatitis with ultraviolet A (UVA), low-dose UVB and combined UVA and UVB: two paired-comparison studies.
Jekler J; Larkö O
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):151-6. PubMed ID: 1814425
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
Trott J; Gerber W; Hammes S; Ockenfels HM
Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
[TBL] [Abstract][Full Text] [Related]
19. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
20. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis.
Tzaneva S; Seeber A; Schwaiger M; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2001 Oct; 45(4):503-7. PubMed ID: 11568738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
